Search research articles

ACERCA DE JoVE

Visión General Liderazgo Blog Centro de Ayuda JoVE

AUTORES

Proceso de Publicación Consejo Editorial Alcance y Políticas Revisión por Pares Preguntas Frecuentes Enviar

BIBLIOTECARIOS

Testimonios Suscripciones Acceso Recursos Consejo Asesor de Bibliotecas Preguntas Frecuentes

INVESTIGACIÓN

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archivo

EDUCACIÓN

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Centro de Recursos para Profesores Sitio de Profesores

Términos y Condiciones de Uso

Política de Privacidad

Videos de Conceptos Relacionados

Coronary Artery Disease IV: Preventive Measures

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...

Pulmonary Embolism I: Introduction

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...

Endocarditis III: Medical Management

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

Cardiopulmonary Resuscitation IV: Pharmacological Management

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por

Same author

Pixel-Level RGBT Fusion Tracking via Heterogeneous Multi-Expert Distillation and Decoupled Representation Learning.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026

Same author

Exploration of the Clinical Assessment and Prognostic Value of Society for Cardiovascular Angiography and Intervention Shock Staging in Patients With Acute Myocardial Infarction and Cardiogenic Shock on Veno-arterial Extracorporeal Membrane Oxygenation Support.

Reviews in cardiovascular medicine·2026

Same author

Unveiling the Power of Multi-Modal Template Update in RGBT Tracking.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2026

Same author

ECMO management in cardiogenic shock-specialized versus non-cardiogenic shock-specialized centers: a registry-based analysis.

BMC anesthesiology·2025

Same author

Clinical study of area-decreasing technique and conventional post-closure technique for V-A ECMO weaning application: study protocol of a randomised controlled trial.

BMJ open·2025

Same author

AFTER: Attention-Based Fusion Router for RGBT Tracking.

IEEE transactions on image processing : a publication of the IEEE Signal Processing Society·2025

Search research articles

Video Experimental Relacionado

Updated: Sep 10, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Profilaxia VA-ECMO durante la ICP compleja de alto riesgo: un ensayo controlado aleatorizado

Chenliang Pan¹, Youqi Zhu¹, Jing Zhao¹

¹The First School of Clinical Medicine of Lanzhou University, Lanzhou, China; Heart Center, The First Hospital of Lanzhou University, Lanzhou, China; Gansu Province Clinical Research Center for Cardiovascular Diseases, Lanzhou, China.

|August 22, 2025

Resumen

La oxigenación extracorporal venarterial profiláctica (VA-ECMO) durante la intervención coronaria percutánea de alto riesgo (ICP) redujo significativamente las complicaciones potencialmente mortales y mejoró los resultados. Este enfoque ofrece una estrategia más segura para pacientes con ICP compleja.

Palabras clave:

Intervención coronaria compleja de alto riesgo la eficacia acontecimientos adversos cardiovasculares y cerebrovasculares importantes seguridad Oxigenación de la membrana extracorporal venosa y arterial

Más Videos Relacionados

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Videos de Experimentos Relacionados

Last Updated: Sep 10, 2025

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Point-of-Care Ultrasound for Peripheral Veno-Arterial Extracorporeal Membrane Oxygenation Without Left Ventricular Venting

Published on: January 17, 2025

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Área de la Ciencia:

Medicina cardiovascular
Cardiología intervencionista
Medicina de cuidados intensivos

Sus antecedentes:

Existen pruebas limitadas para la oxigenación extracorpórea venarterial profiláctica (VA-ECMO) en la intervención coronaria percutánea de alto riesgo (PCI).
Los pacientes con lesiones coronarias complejas a menudo enfrentan riesgos de procedimiento significativos.

Objetivo del estudio:

Evaluar la seguridad y eficacia de la profilaxis VA-ECMO durante la ICP electiva.
Para comparar las tasas de complicaciones y la reducción de la puntuación de SYNTAX en pacientes sometidos a PCI con o sin VA-ECMO profiláctico.

Principales métodos:

Un ensayo aleatorizado en un solo centro en el que participaron 70 pacientes con lesiones coronarias de alto riesgo (puntuación SYNTAX ≥33) que rechazaron la cirugía de derivación.
Los pacientes fueron asignados a VA-ECMO profiláctico (n=34) o a un grupo de control (n=36) antes de la ICP.
Los criterios de valoración primarios incluyeron las tasas de complicaciones y la reducción de la puntuación de SYNTAX después de la ICP.

Principales resultados:

El grupo profiláctico VA-ECMO experimentó tasas significativamente más bajas de complicaciones potencialmente mortales (0% frente a 19,4%, P=0,01).
El VA-ECMO de emergencia fue necesario en el 19,4% del grupo de control.
El grupo VA-ECMO demostró una mayor reducción absoluta en las puntuaciones de SYNTAX (27,2 frente a 22,5, P=0,04).

Conclusiones:

El tratamiento profiláctico VA-ECMO se asocia con una reducción de las complicaciones potencialmente mortales durante la ICP de alto riesgo.
Esta estrategia también conduce a una reducción más significativa en la complejidad de la lesión coronaria medida por las puntuaciones de SYNTAX.
Se necesitan más estudios a gran escala para confirmar estos hallazgos y optimizar las estrategias de gestión.